Virtual Incision’s plans for a robotic space visit highlight the need to make digital surgery devices much smaller.
On today's episode, we discuss what brand new forecasts the forecasting team cooked up in Q2, including influencer marketing spend by platform and tier, luxury ecommerce, and US prescription drug sales. "In Other News," we talk about Apple Pay's meteoric rise and what DoorDash's Q2 performance says about the future of the food delivery space. Tune in to the discussion with our senior forecasting analyst Iwona Drapala and director of forecasting Peter Newman.
We detail the move by retail giants like Walmart into clinical trials and how the data platforms can help maintain equity.
CareCloud has deployed a new chronic care solution in 12 states to address a costly area in healthcare and advance value-based care models.
We unpack a new KLAS survey detailing what health system execs are looking for when selecting a cloud vendor.
Researchers are using NIH funding to see if Apple Watch app algorithm can prevent strokes. We wonder if doctors will trust the data.
Healthcare delivery went digital in 2020, and so did healthcare and pharma ad budgets. In fact, 2020 was the only year in which healthcare and pharma overindexed the overall market digital ad spending growth.
Peloton’s recovery is a long way off: The digital fitness company’s $1.2 billion loss last quarter is the least of its challenges amid declining demand and the return to gyms.
We unpack why the move is only the beginning of Amazon’s healthcare playbook.
Admin headaches lead many clinicians to sell their practices—Alma wants to fix that
Most large US employers say they want to integrate virtual visits with in-person care, per a new report.
LyGenesis looks to disrupt the world of liver transplants: The company is trialing a procedure that gives multiple mini livers to those suffering from liver disease.